RARE is trading 4.1% up today at $29.94 as part of an ongoing rebound in biotech and broader equities after recent volatility.
- There are no fresh Ultragenyx-specific filings, press releases, or analyst calls linked to the move.
- Recent commentary frames the price swings as technical and sentiment-driven following a sharp multi-day run-up and subsequent profit taking in the sector.